Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

October 01, 1987; Volume 32,Issue 4
  • You have access
    [3H]propylbenzilylcholine mustard-labeling of muscarinic cholinergic receptors that selectively couple to phospholipase C or adenylate cyclase in two cultured cell lines.
    M Liang, M W Martin and T K Harden
    Molecular Pharmacology October 1987, 32 (4) 443-449;
  • You have access
    Expression of a cloned muscarinic receptor in A9 L cells.
    M R Brann, N J Buckley, S V Jones and T I Bonner
    Molecular Pharmacology October 1987, 32 (4) 450-455;
  • You have access
    Interaction of a benzomorphan opiate with acetylcholinesterase and the nicotinic acetylcholine receptor.
    B A Coleman, L Michel and R Oswald
    Molecular Pharmacology October 1987, 32 (4) 456-462;
  • You have access
    Xenobiotic metabolizing enzymes are not restricted to parenchymal cells in rat liver.
    P Steinberg, W M Lafranconi, C R Wolf, D J Waxman, F Oesch and T Friedberg
    Molecular Pharmacology October 1987, 32 (4) 463-470;
  • You have access
    The murine Ah locus: a new allele and mapping to chromosome 12.
    A Poland, E Glover and B A Taylor
    Molecular Pharmacology October 1987, 32 (4) 471-478;
  • You have access
    Stimulation of phosphoinositide breakdown in brain synaptoneurosomes by agents that activate sodium influx: antagonism by tetrodotoxin, saxitoxin, and cadmium.
    F Gusovsky, E T McNeal and J W Daly
    Molecular Pharmacology October 1987, 32 (4) 479-487;
  • You have access
    Activators of protein kinase C and cyclic AMP-dependent protein kinase regulate intracellular calcium levels through distinct mechanisms in mouse anterior pituitary tumor cells.
    T Reisine and S Guild
    Molecular Pharmacology October 1987, 32 (4) 488-496;
  • You have access
    Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase.
    B Brüne and V Ullrich
    Molecular Pharmacology October 1987, 32 (4) 497-504;
  • You have access
    Heterogeneity of alpha 1-adrenergic receptors revealed by chlorethylclonidine.
    C Han, P W Abel and K P Minneman
    Molecular Pharmacology October 1987, 32 (4) 505-510;
  • You have access
    Binding of 3H-estradiol-17 beta-(beta-D-glucuronide), a cholestatic organic anion, to rat liver plasma membranes. Evidence consonant with identification of organic anion carriers.
    A L Takacs and M Vore
    Molecular Pharmacology October 1987, 32 (4) 511-518;
  • You have access
    Multiple carriers for uptake of [3H]estradiol-17 beta(beta-D-glucuronide) in isolated rat hepatocytes.
    K L Brouwer, S Durham and M Vore
    Molecular Pharmacology October 1987, 32 (4) 519-523;
  • You have access
    Intracellular phosphorylation of broad-spectrum anti-DNA virus agent (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and inhibition of viral DNA synthesis.
    I Votruba, R Bernaerts, T Sakuma, E De Clercq, A Merta, I Rosenberg and A Holý
    Molecular Pharmacology October 1987, 32 (4) 524-529;
  • You have access
    Antiproliferative and cytotoxic effects of newly discovered halogenated coral prostanoids from the Japanese stolonifer Clavularia viridis on human myeloid leukemia cells in culture.
    A Honda, Y Mori, K Iguchi and Y Yamada
    Molecular Pharmacology October 1987, 32 (4) 530-535;
  • You have access
    Regulation of hepatic sulfotransferase catalyzing the activation of N-hydroxyarylamide and N-hydroxyarylamine by growth hormone.
    Y Yamazoe, S Manabe, N Murayama and R Kato
    Molecular Pharmacology October 1987, 32 (4) 536-541;
  • You have access
    Mechanism of formation and quantitation of imines, pyrroles, and stable nonpyrrole adducts in 2,5-hexanedione-treated protein.
    A P DeCaprio, S J Jackowski and K A Regan
    Molecular Pharmacology October 1987, 32 (4) 542-548;
  • You have access
    Mechanism of S-(1,2-dichlorovinyl)-L-cysteine- and S-(1,2-dichlorovinyl)-L-homocysteine-induced renal mitochondrial toxicity.
    L H Lash and M W Anders
    Molecular Pharmacology October 1987, 32 (4) 549-556;
  • You have access
    On the mechanism of histamine H2 receptor activation.
    F J Luque, F Illas and R Pouplana
    Molecular Pharmacology October 1987, 32 (4) 557-563;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 32, Issue 4
1 Oct 1987
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity
  • P2X7 Positive Modulator Structure-Activity Relationship
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics